§ Funding Round
Series B funding round for ImmPACT Bio raising $140M in January 2022
Series B funding round for ImmPACT Bio raising $140M in January 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Apollo Health Ventures | — | — |
Foresite CapitalLEAD | Organization | — |
MPM Capital | — | — |
OrbiMedLEAD | Organization | — |
RA Capital | — | — |
| Organization | — | |
| Organization | — | |
Bukwang PharmaceuticalLEAD | — | — |
min cuiLEAD | Angel | min cui |
NovartisLEAD | Organization | — |
| Organization | — | |
Surveyor CapitalLEAD | — | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$166M
Top Valuation
-
ImmPACT Bio raised $140M in a Series B round.
The round was announced on 01/01/22.
The round was led by Foresite Capital, OrbiMed, Bukwang Pharmaceutical, min cui, Novartis, rm global partners, Surveyor Capital.
